Peritoneal transport in peritoneal dialysis patients using glucose-based and amino acid-based solutions

Peritoneal Dialysis International

Volumn 27, Issue 5, 2007, Pages 544-553

  Olszowska, Anna ^a   Waniewski, Jacek ^b,c   Werynski, Andrzej ^b   Anderstam, Björn ^c   Lindholm, Bengt ^c   Wankowicz, Zofia ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b INSTITUTE OF BIOCYBERNETICS AND BIOMEDICAL ENGINEERING   (Poland)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amino acid solution; Diffusive mass transport coefficient; Fluid transport; Solute transport

Indexed keywords

CREATININE; DIALYSIS FLUID; DIANEAL; GLUCOSE; NUTRINEAL; POTASSIUM; PROTEIN; SERLAB 125; SERUM ALBUMIN I 125; UNCLASSIFIED DRUG; UREA; AMINO ACID;

ABSORPTION; ADULT; AGED; AMINO ACID TRANSPORT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; FEMALE; FLUID TRANSPORT; HUMAN; INTERMETHOD COMPARISON; MALE; OSMOLALITY; PRIORITY JOURNAL; ACTIVE TRANSPORT; COMPARATIVE STUDY; KINETICS; METABOLISM; MIDDLE AGED; PERITONEUM; PHYSIOLOGY;

ADULT; AGED; AMINO ACIDS; BIOLOGICAL TRANSPORT, ACTIVE; DIALYSIS SOLUTIONS; FEMALE; GLUCOSE; HUMANS; KINETICS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM;

EID: 38449123751     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700514     Document Type: Article

References (22)

1. Twardowski ZJ, Khanna R, Nolph KD. Osmotic agents and uttrafiltration in peritoneal dialysis. Nephron 1986; 42: 93-101.
2. Krediet RT, Boeschoten EW, Zuyderhoudt FMJ, Arisz L. The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambutatory peritoneal dialysis, Clin Nephrol 1987; 27-51-5.
3. Lameire N, Matthys D, Matthys E, Beheydt R. Effects of long term CAPD on carbohydrate and lipid metabolism. Clin Nephrol 1988; 30(Suppl 1):S53-8.
4. Jones MR, Martis L, Algrim CE, Bernard D, Swartz R, Messana J, et al. Amino acid solution for CAPD: rationale and clinical experience. Miner Electrolyte Metab 1992; 18: 309-15.
5. Bergström J. Anorexia in dialysis patients. Semin Nephrol 1996; 16:222-9.
6. Kopple JD, Blumenkrantz MJ, Jones MR, Moran JK, Coburn JW. Plasma amino acid levels and amino acid Losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 1982; 36:395-402.
7. Dulaney JT, Hatch FE. Peritoneal dialysis and Loss of proteins: a review. Kidney Int 1984; 26:253-62.
8. Lindholm B, Bergström J. Nutritional aspects on peritoneal dialysis. Kidney Int Suppl 1992; 38-.S165-71.
9. Heimbürger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38:495-506.
10. Waniewski J, Heimbürger O, Werynski A, Park MS, Lindholm B. Diffusive and convective solute transport in peritoneal dialysis with glucose as an osmotic agent. Artif Organs 1995; 19:295-306.
11. Waniewski J, Heimbürger O, Werynski A, Lindholm B. Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis. Nephrol Dial Transplant 1992; 7:50-6.
12. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
13. Goodship THJ, Lloyd S, McKenzie PW, Earnshaw M, Smeaton I, Bartlett K, et al. Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci (Lond) 1987; 73: 471-8.
14. Oren A, Wu G, Anderson GH, Marliss E, Khanna R, Pettit J, et al. Effective use of amino acid dialysate over four weeks; in CAPD patients. Perit Dial Bull 1983; 3:66-73.
15. Young GA, Dibble JB, Hobson SM, Tompkins L, Gibson J, Turney JH, et al. The use of an amino-acid-based CAPD fluid over 12 weeks. Nephrol Dial Transplant 1989; 4:285-92.
16. Young GA, Dibble JB, Taylor AE, Kendall S, Brownjohn AM. A longitudinal study of the effects of amino acid-based CAPD fluid on amino acid retention and protein losses. Nephrol Dial Transplant 1989; 4:900-5.
17. Suliman ME, Anderstam B, Bergström J. Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients. Kidney lnt 1996; 50:1713-47.
18. Lindholm B, Werynski A, Tranaeus A, Österberg T, Bergström J. Kinetics of peritoneal dialysis with amino acids as osmotic agents. In: Nose Y, Kjellstrand C, Ivanovich P, eds. Progress in Artificial Organs - 1985. Cleveland, OH: ISAIO Press; 1986: 284-8.
19. Park MS, Heimbürger O, Bergström J, Waniewski J, Werynski A, Lindholm B. Peritoneal transport during dialysis with amino acid-based solutions. Perit Dial Int 1993; 13:280-8.
20. Waniewski J, Werynski A, Heimbürger O, Park MS, Lindholm B. Effect of alternative osmotic agents on peritoneal transport. Blood Purif 1993; 11:248-64.
21. Douma CE, de Waart DR, Struijk DG, Krediet RT. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide? Clin Nephrol 1996; 5:295-302.
22. Leypoldt JK. Accuracy of peritoneal membrane solute reflection coefficient. Blood Purif 1992; 10:254-61.